NeuroOne Medical Technologies Corp (NASDAQ: NMTC): A Good Investment At Current Prices?

NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 0.72. At the close of trading, the stock’s price was $0.59, to imply a decrease of -1.67% or -$0.01 in intraday trading. The NMTC share’s 52-week high remains $2.00, putting it -238.98% down since that peak but still an impressive 6.78% since price per share fell to its 52-week low of $0.55. The company has a valuation of $18.18M, with an average of 0.16 million shares in intraday trading volume over the past 10 days and average of 100.94K shares over the past 3 months.

NeuroOne Medical Technologies Corp (NASDAQ:NMTC) trade information

After registering a -1.67% downside in the last session, NeuroOne Medical Technologies Corp (NMTC) has traded red over the past five days. The 5-day price performance for the stock is -5.31%, and -37.23% over 30 days. With these gigs, the year-to-date price performance is -62.66%. Short interest in NeuroOne Medical Technologies Corp (NASDAQ:NMTC) saw shorts transact 0.11 million shares and set a 1.06 days time to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

NMTC Dividends

NeuroOne Medical Technologies Corp has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s Major holders

NeuroOne Medical Technologies Corp insiders hold 16.02% of total outstanding shares, with institutional holders owning 19.43% of the shares at 23.14% float percentage. In total, 19.43% institutions holds shares in the company, led by NANTAHALA CAPITAL MANAGEMENT, LLC. As of 2024-06-30, the company held over 0.95 million shares (or 3.6702% of shares), all amounting to roughly $0.76 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 0.92 million shares, or about 3.5489% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.74 million.